Table 2. Antimicrobial susceptibility pattern of Vibrio cholerae isolates, Papua New Guinea, 2009 to 2011.
Year | Amoxycillin | Chloramphenicol | Ciprofloxacin | Erythromycin | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
# tested | % resistant | % intermediate resistant | # tested | % resistant | % intermediate resistant | # tested | % resistant | % intermediate resistant | # tested | % resistant | % intermediate resistant | |
2009 | 37 | 73.0 | 13.5 | 0 | – | – | 37 | 0.0 | 0.0 | 0 | – | – |
2010 | 215 | 70.7 | 21.9 | 204 | 3.9 | 2.0 | 217 | 1.4 | 0.9 | 203 | 34.5 | 57.6 |
2011 | 50 | 100 | 0.0 | 51 | 0.0 | 0.0 | 51 | 0.0 | 0.0 | 51 | 52.9 | 43.1 |
Total | 302 | 75.8 | 17.2 | 255 | 3.1 | 1.6 | 305 | 1.0 | 0.7 | 254 | 38.2 | 54.7 |
Year | Nalidixic acid | Norfloxacin | Co-trimoxazole | Tetracycline | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
# tested | % resistant | % intermediate resistant | # tested | % resistant | % intermediate resistant | # tested | % resistant | % intermediate resistant | # tested | % resistant | % intermediate resistant | |
2009 | 34 | 0.0 | 0.0 | 37 | 0 | 2.7 | 26 | 3.8 | 0.0 | 36 | 2.8 | 25.0 |
2010 | 215 | 0.5 | 0.9 | 208 | 0 | 0.5 | 205 | 3.9 | 2.0 | 212 | 13.2 | 37.3 |
2011 | 51 | 0.0 | 0.0 | 51 | 0 | 0.0 | 51 | 0.0 | 0.0 | 51 | 0.0 | 11.8 |
Total | 300 | 0.3 | 0.7 | 296 | 0 | 0.7 | 282 | 3.2 | 1.4 | 299 | 9.7 | 31.4 |